Heart Disease News and Research

Latest Heart Disease News and Research

Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with or without existing diabetes, while also achieving greater weight loss.

28 Aug 2024

Primary care providers key to addressing emotional eating

Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts.

28 Aug 2024

Hereditary cardiac amyloidosis more common in the UK than previously thought

More people in the UK are at risk of a hereditary form of cardiac amyloidosis, a potentially fatal heart condition, than previously thought, according to a new study led by researchers at UCL (University College London) and Queen Mary University of London.

28 Aug 2024

Pediatric heart transplant waitlist fails to prioritize sickest patients, study shows

The method used across the United States to wait-list children for heart transplants does not consistently rank the sickest patients first, according to a new study led by Stanford Medicine experts.

28 Aug 2024

TCT 2024 to feature latest advances in interventional cardiovascular medicine

The Cardiovascular Research Foundation is pleased to announce the late-breaking clinical trials and science to be featured at TCT 2024.

28 Aug 2024

Research highlights potential of blood epigenetics for dementia risk assessment

New research suggests that epigenetic markers in the blood could be useful for understanding dementia risk.

28 Aug 2024

In-person contact decreases levels of loneliness in older people

In-person contact helps lead to lower levels of loneliness in older people, but other ways of staying in touch, such as phoning, emailing or texting, are not as effective in lowering loneliness, a team of researchers at The University of Texas at Austin and the University of Michigan have found.

28 Aug 2024

Robotic arm-based, 5G-enabled remote echocardiograms show high diagnostic accuracy

New research presented at this year's ESC Congress 2024 in London, UK (30 Aug – 2 Sept) shows that performing echocardiograms remotely using a 5G cellular network has similar accuracy to those performed in person by cardiologists.

28 Aug 2024

Recreational drug users three times more likely to experience repeat cardiovascular events

New research presented at this year's ESC Congress 2024 in London, UK (30 Aug – 2 Sept) shows that, among patients admitted to the intensive cardiac care unit (ICCU), those with a recent history of recreational drug use are three times more likely than those with no history to experience a repeat serious cardiovascular event within one year.

28 Aug 2024

Study introduces a novel approach to mapping protein-receptor interactions

One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells.

28 Aug 2024

New study develops enhanced mortality prediction model for COPD patients

Innovative probabilistic graph models identify unique factors linked to COPD mortality, paving the way for targeted interventions and improved patient outcomes.

28 Aug 2024

A study confirms that smoking significantly increases the risk of stroke

Findings indicate smoking elevates stroke risk, particularly in older males with comorbidities, underscoring the need for targeted prevention strategies.

28 Aug 2024

Novel biochip diagnoses deadly brain cancer in under an hour

Researchers at the University of Notre Dame have developed a novel, automated device capable of diagnosing glioblastoma, a fast-growing and incurable brain cancer, in less than an hour. The average glioblastoma patient survives 12-18 months after diagnosis.

28 Aug 2024

LncRNA ZNF593-AS offers hope for heart disease treatment

The research presented in the article delves into the regulatory role of the long non-coding RNA (lncRNA) ZNF593-AS in cardiac hypertrophy and myocardial remodeling, processes that are pivotal in the progression of heart failure and other cardiovascular diseases. The study uncovers how ZNF593-AS exerts its inhibitory effects by upregulating the expression of Mitofusin 2 (Mfn2), a protein known for its role in the regulation of mitochondrial dynamics and cellular metabolism.

28 Aug 2024

$120 million gift boosts UCLA’s efforts in immunotherapy and innovation

UCLA has received a $120 million commitment from surgeon, inventor and philanthropist Dr. Gary Michelson and his wife, Alya, to kick-start the California Institute for Immunology and Immunotherapy, an innovative public-private partnership aimed at spurring breakthrough discoveries that prevent and cure diseases and catalyze economic growth and innovation in Los Angeles.

27 Aug 2024

Green Heart Louisville Project links more trees to lower inflammation levels

The University of Louisville's groundbreaking Green Heart Louisville Project has found that people living in neighborhoods where the number of trees and shrubs was more than doubled showed lower levels of a blood marker of inflammation than those living outside the planted areas.

27 Aug 2024

Innovative AI tool targets missing data to enhance sepsis risk predictions

A proposed artificial intelligence tool to support clinician decision-making about hospital patients at risk for sepsis has an unusual feature: accounting for its lack of certainty and suggesting what demographic data, vital signs and lab test results it needs to improve its predictive performance.

27 Aug 2024

Urban noise pollution found to have significant negative impact on heart health

Research from two studies in different European cities1,2 highlights that urban noise pollution has a significant negative impact on heart health, according to data presented at ESC Congress 2024.

27 Aug 2024

Menopause transition linked to changes in blood cholesterol and cardiovascular risk

New research presented at the ESC Congress 2024 in London, UK (30 August - 2 September) shows that women in the menopause transition period show changes in their blood cholesterol profiles which could have an adverse impact on their cardiovascular health.

27 Aug 2024

New ESC atlas data highlights disparities in cardiovascular disease mortality

Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.

27 Aug 2024